Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Cannabidiol for Treatment of Child and Adolescent Psychiatric Disorders
Charlena Janice Melnyk
,
Karen Dineen Wagner
Psychiatry and Behavioral Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cannabidiol for Treatment of Child and Adolescent Psychiatric Disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Psychiatric Disorders
100%
Cannabidiol
100%
Mental Health Conditions
50%
Autism Spectrum Disorder
50%
Child Mental Health
50%
Inpatient Treatment
50%
Treating children
50%
Social Anxiety Disorder
50%
Tetrahydrocannabinol
50%
Adolescent Mental Health
50%
Childhood Psychiatric Disorders
50%
Pharmacology, Toxicology and Pharmaceutical Science
Base
100%
Social Phobia
100%
Tetrahydrocannabinol
100%
Cannabidiol
100%
Autism
100%
Medicine and Dentistry
Cannabidiol
100%
Adolescence
100%
Neurodevelopmental Disorder
100%
Base
33%
Mental Health
33%
Social Phobia
33%
Pervasive Developmental Disorder
33%
Tetrahydrocannabinol
33%
Neuroscience
Mental Disorder
100%
Cannabidiol
100%
Pervasive Developmental Disorder
50%
Tetrahydrocannabinol
50%
Social Anxiety Disorder
50%
Childhood Psychiatric Disorders
50%
Psychology
Adolescence
100%
Social Anxiety Disorder
50%
Child and Adolescent Mental Health
50%
Pervasive Developmental Disorder
50%
Autism
50%